-
What is it?
EPP's Certified Pricing Manager Pharma –program is expertly designed around the know-what and the know-how to implement pricing peak performance in pharma pricing!
The idea is to make a real impact on the pricing maturity development in your organization. The CPM Pharma program is not only an intensive executive program. It is also an intense all-round experience with a group of international and cross-industrial talented peers.
Objectives
How you benefit of Certified Pricing Manager Pharma:
- Gain actionable the ‘know-how’ and ‘know-what’ to excel with pricing in Pharma
- Install a value strategy and value based pricing
- Develop a regional and global pricing strategy
- Set your right priorities for next 12 months pricing roadmap
- Become the pricing ambassador in your company
- Become a Certified Pricing Manager Pharma and get rewarded
Participant Profile
EPP's Certified Pricing Manager Pharma program has been developed for pricing professionals from global, regional pricing and market access teams or local pricing and market access teams:
- Global Pricing and Market Access Director
- Regional Pricing and Market Access Director
- Health Economics and Pricing manager
- Market Access Manager
- Pricing and Reimbursement Manager/Specialist
- Pricing and Contracts Manager
- Pricing and Tender Manager
- Pricing Analyst
-
What participants will learn:
Top important topics that will be covered during the CPM Pharma program
- Impact and the role of Pricing for Pharma
- Learn to define and focus on our challenges at every stage of your pricing maturity
- Innovative pricing models and new trends in Pharma Pricing
- P&R systems and trends
- Development of a regional pricing strategy for USA market, EU markets, Japan market and emerging markets.
- Contracting and net pricing approaches
- Tender Management: evolution and best practices
- Understanding the role of pricing across the product life cycle
- Loss of exclusivity
- Pricing Research
- Change Management
- Implementation of pricing strategy
- Start with your CPM project and your priorities for the upcoming 12 months
How participants learn:
- Learn from our world-class CPM Pharma faculty, who are leading authorities
- Gain insights from CPM Pharma faculty and industry participants
- External view of pricing excellence
- Gain key industry insights
- Benchmarking of pricing in comparison to other CPM Pharma Participants
- Applying CPM learning in a business case
Learning experience:
- 4 days action learning in a vibrant city
- Intense all-round learning experience with a group of international and cross-industrial talented pricing peers
- Interactive learning sessions
- Network opportunities with a global peer group, sharing personal experiences and debating the industry’s latest hot topics
-
CPM Pharma FacultyThe CPM Pharma faculty consists of a selected group of international experienced cross-industry pricing experts and dedicated CPM trainers.
All trainers are open to share and discuss the best pricing practices with you and are excited to train on the EPP Certification Programs® because participants are an exceptional group of pricing practitioners on their path to increase the pricing maturity of their organizations.
We do not teach, we train and develop.
You will learn, discuss and reflect - and you will bring the learnings into action. -
Venue Information - Titanic Chaussee Berlin
Titanic Chaussee Berlin is located in the heart of Berlin, close to main train station and just a few minutes from the modern art museum Hamburger Bahnhof. The hotel puts you right on the edge of Berlin’s most creative neighborhood Hackescher Markt full of vibrant culture, cutting-edge architecture, fabulous food, intense parties and tangible history. Just a stroll away the area between Hackescher Markt and Torstraße are buzzing with pure lifestyle fabulous boutiques and great art galleries.
ACCOMMODATION
Please visit https://www.titanic.com.tr/titanic-chaussee-berlin or call +49 30 3116 8580 in order to get the best available room rates.
LOCATION
Chausseestraße 30, Berlin, 10115, Germany
-
Dates
Type : In-Person
Start : 23 Apr 2024 at 09:00
End : 26 Apr 2024 at 17:00
Duration : 4 days
Location : BerlinTraining Fees
The fee for CPM Pharma Edition is €5350.00
The program fee includes
- All learning materials
- Certification fee
- All EPP organized lunches (4) and coffee breaks during the program days
- Evening activity including a CPM dinner
Please note that the program fee does not include travel expenses, accommodation, individually organized dinners and other incidentals. VAT is applicable based on locations and companies.
EPP reserves the right to cancel or postpone events/sessions, or alter the country, location or venue in case of force-majeur, unforeseen circumstances, or if minimum registration numbers are not met. In case of such cancellation, postponement or alteration by EPP, registrants will receive a rollover credit for attendance at the rescheduled sessions. For more information please have a look at our Terms and Conditions.
Training Fee Discounts
Joining the CPM program as a team, or with your pricing colleagues, offer additional benefits such as team alignment, reflection, and fruitful discussions. We understand that and provide group rates to facilitate your peer learning.
- €5350 full training fee
- €4850 team 2 registration
- €4300 team 3 and more registration fee
- 10% discount for our CPM Alumni
- €300 discount for EPP Prime Members
* fees per participant
-
How Does the Biden Administration Want to ‘Take on Pharma?’
- Democratic President-elect Joe Biden and his administration are poised to take the reins from President Donald Trump, who had just begun to more stringently address prescription drug prices in the U.S. via Executive Orders (EOs) aimed at introducing an American version of reference pricing.
- Throughout his campaign, Biden has promised to expand access to health care through the “BidenPlan,” an evolution of former President Barack Obama’s Affordable Care Act, dubbed “Obamacare,”while “taking on big pharma” and reining in “runaway” drug prices.
- Biden has also announced intentions to set up a government-run, Institute for Clinical and Economic Review (ICER) -style Health Technology Assessment (HTA) body, as ICER is currently an autonomous body to the U.S. government